The regulation requires efficacy tests to validate two important criteria: fog homogeneous diffusion and efficacy in biocharge reduction.
The efficacy of a diffusion can be evaluated in a simple and relatively fast way. Chemical and/or biological indicators are used to guarantee the efficiency of the biodecontamination and the safety of all users. The disinfection protocols designed with Devea are approved by the customers according to their specifications: reduction of microbial populations by 4-log10 (99.99%), 5-log10 (99.999%) or 6-log10 (99.9999%).
The ASD device/product pair must be approved (requirements of the EN 17272 standards of 2020). Disinfectants must not only comply with the BPR (Biocidal Products Regulation) Reg (EU) 528/2012, but also be registered and authorized for marketing. Devea is the only French ASD company to be granted a Marketing Authorization for its Phileas® solutions (MA FR-2019-0071). This Marketing Authorization validates the diffuser / biocide couple and the achieved results.